Tag Archives: Shire

Feds Threaten to Pull ProAmatine for Lack of Postmarket Data (Updated 8/18)

By George Koroneos | Published: August 16, 2010
Image via Wikipedia FDA on Monday announced that it was looking to withdraw approval for the low-blood-pressure treatment midodrine hydrochloride because the companies manufacturing the drug failed to provide data from post-approval studies. The kicker: The drug was approved 14 years ago. FDA gave midodrine hydrochloride—branded by Shire as ProAmatine and produced by a half-dozen generics firms—the green [...]
Posted in FDA | Also tagged , , , , , , , | 1 Comment

Vertex Names Emmens President, Future CEO

By Cassandra Blohowiak | Published: February 6, 2009
Vertex Pharmaceuticals Thursday appointed Matthew Emmens president, with an expected transition to CEO and chairman in May 2009, when current CEO Joshua Boger is set to retire. Emmens, a 35-year pharma industry veteran, has been a Vertex director since 2004. He previously served as CEO of Shire plc and Astra Merck Inc., and as president for [...]
Posted in People | Also tagged , , , | Leave a comment

Amid Big Pharma Woes, Shire in “Best Shape Ever”

By Joanna Breitstein | Published: November 17, 2008
Angus Russell, Shire’s longtime CFO—now CEO—likens the failing US automobile industry to pharma. “All the problems with the automobile industry were a long time coming,” he says. “It’s just that the SUVs and the relatively cheap price of gas created a bubble, just like a booming economy and blockbusters.” But now that the bubble has burst, [...]
Posted in Deals, Emerging Markets, R&D, Strategy | Also tagged , | 1 Comment

Is FDA Watching YouTube?

By George Koroneos | Published: October 10, 2008
Two weeks ago, Shire received a warning letter for posting a sponsored testimonial on YouTube without including risk information. Shire was very open when I called them up and admitted that the video was posted by accident and immediately removed when it was brought to the company’s attention. While I’m not 100 percent positive, it [...]
Posted in E-Media, Marketing, Regulatory | Also tagged , , , , , , , | 6 Comments